COVID-19 Message & Information
A message from our Regulatory, Quality & Compliance Officer on Managing COVID-19
ABOUT BIOWELLNESS GROUP
The future of Regenerative medicine is quite promising! The physician and patient reported outcomes include accelerated injury healing, significant pain relief, and rebuilding of injured tissue, bone, and even nerves. At BioWellness Group, we have researched the market and we only partner with top quality manufacturers and recommend products with a solid safety record. Patients are actively seeking cellular therapy as an alternative to surgery and pharmaceuticals. We offer the products, information, and access to trainings.
All the time new studies are being conducted on the benefits of using regenerative products as an addition to everyday procedures. Find out the latest industry research that support the human body.
BioWellness Group only partners with manufacturers that maintain the highest safety and quality process designed to prevent, detect and correct deficiencies that may lead to circumstances that increase the risk of introduction, transmission and spread of communicable diseases.
The processing of these products aligns with the minimal manipulation requirements identified by the FDA to ensure they are free from potential contaminants or harmful components. Further, the processing of the products does not alter the relevant biological characteristics of cells or tissues.